Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Income from Continuing Operations: 2017-2024

Historic Income from Continuing Operations for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $23.2 million.

  • Puma Biotechnology's Income from Continuing Operations fell 56.47% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year increase of 28.66%. This contributed to the annual value of $23.2 million for FY2024, which is 7.47% up from last year.
  • According to the latest figures from FY2024, Puma Biotechnology's Income from Continuing Operations is $23.2 million, which was up 7.47% from $21.6 million recorded in FY2023.
  • Over the past 5 years, Puma Biotechnology's Income from Continuing Operations peaked at $23.2 million during FY2024, and registered a low of -$60.0 million during FY2020.
  • Over the past 3 years, Puma Biotechnology's median Income from Continuing Operations value was $21.6 million (recorded in 2023), while the average stood at $14.9 million.
  • Data for Puma Biotechnology's Income from Continuing Operations shows a peak YoY soared of 1,079,450.00% (in 2023) over the last 5 years.
  • Puma Biotechnology's Income from Continuing Operations (Yearly) stood at -$60.0 million in 2020, then soared by 51.45% to -$29.1 million in 2021, then surged by 100.01% to $2,000 in 2022, then spiked by 1,079,450.00% to $21.6 million in 2023, then climbed by 7.47% to $23.2 million in 2024.